A különféle beszélgetéses adatgyűjtő szoftverek elfogadhatóságának, megvalósíthatóságának és használhatóságának értékelése (CADS)

Study Design and Methodology:

This is a research study designed to systematically evaluate various digital biopsychosocial data collection software platforms in a population of patients with chronic pain. The study will assess three key dimensions: acceptability (whether patients find the tools appropriate and are willing to use them), feasibility (whether the tools can be practically implemented in real-world clinical settings), and usability (how easy and intuitive the tools are for patients to interact with).

The study employs a comparative design to rigorously evaluate different approaches to collecting biopsychosocial information from patients with chronic pain. Participants will be assigned to use different data collection methods, allowing researchers to compare the effectiveness, user experience, and practical implementation considerations across multiple approaches. This comparative framework is essential for determining which methods work best for patients and healthcare systems.

Background and Rationale:

Chronic pain is a complex, multifaceted condition that requires comprehensive assessment of biological, psychological, and social factors to effectively understand and manage. The biopsychosocial model of pain recognizes that pain experiences cannot be fully understood by examining biological factors alone. Psychological factors such as mood, stress, coping strategies, and pain-related beliefs significantly influence pain perception and disability. Social factors including work status, family support, social isolation, and economic circumstances also play crucial roles in the chronic pain experience.

Traditional data collection methods in clinical settings often rely on paper-based questionnaires, structured interviews, or electronic forms that may not capture the nuanced, contextual information needed for holistic pain management. These conventional approaches have several limitations: they may be time-consuming for both patients and providers, can suffer from incomplete responses, may not adapt to individual patient circumstances, and often fail to capture the interconnected nature of biopsychosocial factors. Additionally, patients may experience questionnaire fatigue when faced with lengthy assessment batteries, potentially compromising data quality.

The emergence of digital health technologies has created new opportunities for patient-centered data collection. Digital platforms can potentially offer more engaging, adaptive, and comprehensive methods for gathering biopsychosocial information. However, before such tools can be widely adopted in clinical practice, it is essential to rigorously evaluate whether they meet the needs of both patients and healthcare providers. Key questions include: Do patients find these tools acceptable? Can they be practically implemented in various settings? Are they intuitive and easy for patients to use? How do they compare to existing methods?

Study Procedures and Participant Experience:

Participants enrolled in this study will engage with digital software platforms designed to collect biopsychosocial data relevant to their chronic pain condition. The software will gather information about various aspects of their pain experience, physical functioning, emotional well-being, social circumstances, and other relevant health factors.

Depending on their assigned study group, participants may interact with the data collection tools in different settings and formats. Some participants will complete study procedures at home using their own devices or equipment provided by the study team. Other participants will visit the MIT.nano Immersion Lab, a specialized research facility designed for studying human-technology interactions in controlled environments. The MIT.nano Immersion Lab provides advanced technical infrastructure and a setting specifically designed to evaluate innovative data collection approaches.

The flexibility in study locations allows researchers to evaluate how different environmental contexts may affect the data collection experience. Home-based participation offers convenience and the comfort of a familiar environment, while the laboratory setting provides controlled conditions and access to specialized equipment. Understanding how location affects acceptability, feasibility, and usability is an important aspect of determining how these tools might be deployed in real-world clinical practice.

Throughout their participation, patients will be asked to provide comprehensive feedback on their experience with the data collection methods. This feedback will help researchers understand the acceptability of the tools from the patient perspective, including factors such as comfort level with the technology, perceived relevance of the information being collected, ease of use, time required, and overall satisfaction with the experience. Participants may be asked to complete questionnaires, provide verbal feedback, or participate in debriefing sessions to share their perspectives.

Comprehensive Evaluation Framework:

The study will employ multiple methods and metrics to thoroughly evaluate the digital data collection software:

Acceptability Assessment: Researchers will evaluate whether patients find the software acceptable for collecting sensitive health information. Acceptability encompasses multiple dimensions including appropriateness (whether patients feel the method is suitable for collecting health data), comfort (whether patients feel at ease during the data collection process), willingness (whether patients are open to using this method in the future), and trust (whether patients feel confident that their information is being handled appropriately). The study will systematically document patient attitudes, preferences, concerns, and suggestions for improvement.

Acceptability may vary across different patient subgroups, and the study will examine whether factors such as age, prior technology experience, pain severity, or other characteristics influence how patients respond to the data collection methods. Understanding these variations is crucial for ensuring that new tools are accessible and acceptable to diverse patient populations.

Feasibility Assessment: The study will examine practical considerations related to implementing these tools in clinical settings and real-world environments. Feasibility assessment includes evaluating technical requirements (such as hardware, software, and internet connectivity needs), integration with existing healthcare workflows and electronic health record systems, time required for patient interactions, staff training needs, technical reliability and system stability, cost considerations, and any barriers to implementation that emerge during the study.

Feasibility is assessed from multiple perspectives including the patient viewpoint (Can patients realistically use these tools given their circumstances?), the provider perspective (Can healthcare teams incorporate these tools into their practice?), and the systems level (Can healthcare organizations successfully deploy and maintain these technologies?). The study will document technical issues, logistical challenges, and resource requirements to provide a realistic assessment of implementation feasibility.

Usability Assessment: Researchers will assess how easy the software is for patients to use and how well the design meets user needs. Usability evaluation draws on established frameworks from human-computer interaction and user experience research. Key usability dimensions include learnability (how quickly can new users understand how to use the system?), efficiency (how rapidly can users complete tasks?), memorability (can users easily use the system again after a period of not using it?), error prevention and recovery (does the system help prevent errors and allow users to recover when errors occur?), and satisfaction (how pleasant is the system to use?).

The study will identify specific usability issues that patients encounter, such as confusing instructions, unclear navigation, technical difficulties, or design elements that create frustration. This detailed feedback will inform iterative improvements to the software design. Special attention will be paid to ensuring that the tools are usable for patients with varying levels of technical proficiency and those who may have physical or cognitive limitations related to their chronic pain condition.

Population Focus and Clinical Context:

The study specifically focuses on patients with chronic pain because this population faces unique challenges in healthcare data collection and represents a significant public health concern. Chronic pain affects an estimated 20-50% of the adult population in developed countries and is one of the most common reasons for seeking medical care. The economic burden of chronic pain is substantial, including direct medical costs, lost productivity, and reduced quality of life.

Chronic pain patients often have complex medical histories involving multiple healthcare providers, various treatment approaches, and numerous medications. Many have comorbid conditions such as depression, anxiety, sleep disorders, or other chronic illnesses that interact with their pain condition. The multidimensional nature of chronic pain makes it an ideal condition for evaluating comprehensive biopsychosocial data collection tools.

Furthermore, chronic pain patients frequently interact with healthcare systems over extended periods, often for years or decades. This longitudinal nature of care makes efficient, effective, and patient-friendly data collection particularly valuable. If patients find data collection burdensome or irrelevant, engagement with care may suffer. Conversely, if data collection is perceived as valuable and manageable, it may enhance the therapeutic relationship and improve outcomes.

The chronic pain population also exhibits significant heterogeneity in terms of pain conditions (back pain, neuropathic pain, fibromyalgia, arthritis, etc.), age ranges, functional status, and psychosocial circumstances. This diversity provides an excellent opportunity to evaluate whether digital data collection tools work across different patient subgroups or whether certain approaches are better suited to specific populations.

Clinical Significance and Healthcare Impact:

The findings from this study have the potential to significantly impact how patient information is gathered in clinical settings. Current healthcare practice faces multiple challenges related to data collection: providers have limited time with patients, electronic health records are often cumbersome to use, patient-reported information may be incomplete, and the biopsychosocial factors crucial for understanding chronic conditions are frequently under-documented.

If the digital software platforms evaluated in this study prove to be acceptable, feasible, and usable for chronic pain patients, they could represent a significant advancement in healthcare data collection. Potential benefits include: reducing administrative burden on healthcare providers by automating aspects of data collection; improving the completeness and quality of patient data by using systematic collection methods; enhancing patient engagement in their own care by providing more interactive and meaningful data collection experiences; enabling more frequent monitoring of patient status between clinical visits; providing richer, more nuanced insights into the biopsychosocial factors affecting health outcomes; and creating structured data that can be more easily analyzed to identify patterns and inform treatment decisions.

Beyond chronic pain, the lessons learned from this study may have broader applicability to other chronic conditions that require comprehensive biopsychosocial assessment, such as mental health disorders, cardiovascular disease, diabetes, and cancer. The methodological approaches used in this study to evaluate acceptability, feasibility, and usability can serve as a model for assessing other digital health innovations.

Study Settings and Environmental Considerations:

The research utilizes two distinct environments to evaluate the digital data collection tools, each offering unique advantages and insights:

Home-Based Participation: Many participants will complete study procedures in their own homes. Home-based participation reflects the growing trend toward remote healthcare delivery and patient engagement outside traditional clinical settings. Evaluating tools in home environments provides ecological validity-understanding how they perform in the real-world contexts where patients actually live. Home settings may be more comfortable and convenient for patients, potentially improving participation rates and data quality. However, home environments also present challenges such as variable internet connectivity, diverse device capabilities, potential distractions, and limited technical support availability. Assessing performance in home settings helps researchers understand whether the tools are robust enough for widespread deployment.

MIT.nano Immersion Lab: Selected participants will complete study procedures at the MIT.nano Immersion Lab, a state-of-the-art facility specifically designed for studying human interactions with advanced technologies. The Immersion Lab provides controlled environmental conditions, specialized equipment, and technical infrastructure that may not be available in home or typical clinical settings. This laboratory environment allows researchers to rigorously evaluate the tools under optimal conditions and to conduct detailed assessments of user behavior and experience. The lab setting also facilitates direct observation by researchers, enabling collection of rich qualitative data about how patients interact with the technology. Additionally, the lab can accommodate equipment and technical requirements that might not be feasible for home-based deployment, allowing evaluation of more advanced or experimental approaches.

By utilizing both home and laboratory settings, the study can compare how environmental context influences the acceptability, feasibility, and usability of the data collection tools. This dual-setting approach provides a more comprehensive understanding of how the tools might perform across the spectrum of potential deployment scenarios, from controlled clinical or research environments to unstructured home settings.

Participant Safety and Ethical Considerations:

The study has received approval from WCG IRB (formerly Western Institutional Review Board), an independent ethics review board that ensures research protects participant rights, safety, and welfare. The IRB has reviewed the study protocol, consent procedures, and data protection measures to ensure they meet federal regulations and ethical standards for human subjects research.

Given that the study involves collecting sensitive health information through digital platforms, comprehensive measures are in place to protect participant privacy and ensure data security. All data collection, storage, and transmission procedures comply with applicable regulations including HIPAA (Health Insurance Portability and Accountability Act) for the protection of health information. Participants are fully informed about what information will be collected, how it will be used, who will have access to it, and how it will be protected.

Participation in this study is entirely voluntary. Patients are free to decline participation without any effect on their medical care. Those who enroll can withdraw from the study at any time, for any reason, without penalty or impact on their healthcare relationships. The informed consent process ensures that participants understand the nature of the research, what their participation involves, any potential risks or discomforts, potential benefits, alternatives to participation, and their rights as research subjects.

Data Collection and Analysis Approach:

The study will collect both quantitative and qualitative data to provide a comprehensive evaluation of the digital data collection tools. Quantitative data may include completion rates, time to complete data collection, number of technical issues encountered, standardized usability and satisfaction scores, and metrics describing the data collected. Qualitative data will include open-ended participant feedback, observations of user behavior, and detailed descriptions of implementation challenges and successes.

This mixed-methods approach allows for triangulation-using multiple data sources to develop a robust and nuanced understanding of how well the tools work. Quantitative metrics provide objective, standardizable measures that can be compared across groups and analyzed statistically. Qualitative data provides context, explanations, and insights into why certain patterns emerge and how participants experience the tools on a personal level.

Collaborative Approach and Stakeholder Engagement:

The study is designed to gather input from multiple stakeholders in the chronic pain care ecosystem. By including patients as active participants in evaluating these tools, the research ensures that the technology development is truly patient-centered and responsive to patient needs and preferences. Patient input is valued not just as data to be collected, but as expert knowledge about living with chronic pain and navigating healthcare systems.

Healthcare providers are encouraged to participate by referring eligible patients to the study. Provider involvement serves multiple purposes: it helps ensure that the study population is representative of real-world chronic pain patients seen in clinical practice; it allows providers to learn about emerging data collection approaches; and it creates opportunities for feedback about how such tools might fit into clinical workflows. Providers who refer patients can contact AugMend Health Inc. to learn more about the study and referral procedures.

The collaborative approach extends to the research team itself, which brings together expertise in chronic pain management, digital health technology, user experience research, and clinical trial methodology. This interdisciplinary collaboration ensures that the study addresses technical, clinical, and human factors considerations.

Innovation and Future Directions:

This research represents an important step in understanding how digital technologies can be applied to healthcare data collection, particularly for complex chronic conditions. The insights gained will serve multiple purposes: informing the refinement and improvement of the specific software being tested; contributing to the broader knowledge base regarding digital health tool implementation; advancing understanding of patient preferences for technology-mediated healthcare interactions; identifying best practices for biopsychosocial data collection in chronic disease populations; and informing regulatory and policy discussions about digital health tools.

The study is designed not just to answer whether specific tools work, but to generate generalizable knowledge about the factors that influence success or failure of digital health data collection tools. By systematically evaluating acceptability, feasibility, and usability, the research will identify principles and practices that can guide future innovation in this rapidly evolving field.

As healthcare increasingly incorporates digital tools and remote monitoring, understanding how to design and implement these tools effectively becomes crucial. This study contributes to that understanding by rigorously evaluating user experience, practical implementation considerations, and patient perspectives. The findings will help ensure that as healthcare adopts new technologies, these technologies truly serve the needs of patients and providers rather than creating new burdens or barriers to care.

Potential Impact on Chronic Pain Care:

Chronic pain management faces numerous challenges including limited treatment options, variability in treatment response, complex biopsychosocial contributors, and fragmented care across multiple providers. Better data collection tools have the potential to address some of these challenges by: providing clinicians with more comprehensive information about patients' pain experiences and functional status; enabling more personalized treatment planning based on detailed biopsychosocial profiles; facilitating communication between patients and providers about pain management goals and progress; supporting research to identify predictors of treatment response and develop better interventions; and empowering patients to track their own symptoms and participate more actively in their care.

While this study evaluates data collection tools rather than pain treatments per se, improvements in how pain information is gathered could indirectly lead to better pain management outcomes. Clinical decisions are only as good as the information on which they are based. If digital data collection tools can provide clinicians with richer, more accurate, and more timely information about their patients' conditions, this may translate into better treatment decisions and improved patient outcomes.

The study's focus on patient perspectives-whether patients find these tools acceptable and usable-is crucial for ensuring that any new data collection approaches will be adopted and used consistently in practice. Even the most sophisticated technology will fail if patients find it burdensome, confusing, or irrelevant. By centering patient experience in the evaluation, this research aims to identify approaches that patients will engage with willingly and consistently.